Fuguo Liu1, Rizwan Romee1

  • 1Division of Transplantation and Cellular Therapies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

Cell stem cell
|September 6, 2024
PubMed
概括

从免疫细胞中去除粘附蛋白CD54和CD58可以防止排斥,同时保持功能. 这一突破推动了通用"现成"的全源细胞疗法的创造.